Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09ZNV
|
||||
| Former ID |
DNC014862
|
||||
| Drug Name |
CGP-029482
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530101] | ||
| Formula |
C17H12N2O3
|
||||
| Canonical SMILES |
C1=CC=C2C(=C1)C(=C3N2C4=CC=CC=C4C(=O)N3)CC(=O)O
|
||||
| InChI |
1S/C17H12N2O3/c20-15(21)9-12-10-5-1-3-7-13(10)19-14-8-4-2-6-11(14)17(22)18-16(12)19/h1-8H,9H2,(H,18,22)(H,20,21)
|
||||
| InChIKey |
INSBKYCYLCEBOD-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Casein kinase II, alpha chain | Target Info | Inhibitor | [530101] | |
| NetPath Pathway | FSH Signaling Pathway | ||||
| Pathway Interaction Database | BCR signaling pathway | ||||
| Atypical NF-kappaB pathway | |||||
| DNA-PK pathway in nonhomologous end joining | |||||
| Presenilin action in Notch and Wnt signaling | |||||
| Role of Calcineurin-dependent NFAT signaling in lymphocytes | |||||
| E-cadherin signaling in the nascent adherens junction | |||||
| Lissencephaly gene (LIS1) in neuronal migration and development | |||||
| PDGFR-alpha signaling pathway | |||||
| Signaling mediated by p38-alpha and p38-beta | |||||
| Alpha-synuclein signaling | |||||
| References | |||||